Approaches to the development of broadly protective HIV vaccines: challenges posed by the genetic, biological and antigenic variability of HIV-1: Report from a meeting of the WHO-UNAIDS Vaccine Advisory Committee Geneva, 21-23 February 2000

AIDS. 2001 Apr 13;15(6):W1-W25.
No abstract available

Publication types

  • Congress

MeSH terms

  • AIDS Vaccines / biosynthesis*
  • AIDS Vaccines / immunology
  • Antibody Formation
  • Antigenic Variation
  • HIV Infections / prevention & control*
  • HIV-1 / genetics*
  • HIV-1 / immunology
  • HIV-1 / pathogenicity
  • Humans
  • Immunity, Cellular
  • Immunotherapy, Active*
  • Public Policy
  • Viral Load
  • World Health Organization

Substances

  • AIDS Vaccines